# Anti-Retroviral Therapy (ART)

> Anti-retroviral therapy is the cornerstone of HIV treatment, aimed at reducing viral load, maintaining immune function, and preventing HIV-related complications and transmission.

## Classes of Anti-Retroviral Drugs

### 1. Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

- **Mechanism of Action**: Inhibit HIV reverse transcriptase by incorporating into the viral DNA chain, causing termination.
- **Examples**: Zidovudine (AZT), Lamivudine (3TC), Tenofovir (TDF), Emtricitabine (FTC).
- **Side Effects**: Lactic acidosis, hepatomegaly with steatosis, bone marrow suppression (Zidovudine), renal toxicity (Tenofovir).

### 2. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

- **Mechanism of Action**: Bind to and inhibit HIV reverse transcriptase at a different site from NRTIs.
- **Examples**: Efavirenz (EFV), Nevirapine (NVP), Etravirine (ETR).
- **Side Effects**: Rash, hepatotoxicity, neuropsychiatric symptoms (Efavirenz).

### 3. Protease Inhibitors (PIs)

- **Mechanism of Action**: Inhibit HIV protease, preventing the cleavage of viral polyproteins, leading to the production of immature, non-infectious viral particles.
- **Examples**: Lopinavir/ritonavir (LPV/r), Atazanavir (ATV), Darunavir (DRV).
- **Side Effects**: Gastrointestinal disturbances, hyperlipidemia, insulin resistance, lipodystrophy, hepatotoxicity.

### 4. Integrase Strand Transfer Inhibitors (INSTIs)

- **Mechanism of Action**: Inhibit HIV integrase, preventing the integration of viral DNA into the host genome.
- **Examples**: Raltegravir (RAL), Elvitegravir (EVG), Dolutegravir (DTG).
- **Side Effects**: Insomnia, headache, weight gain, rare instances of hypersensitivity reactions.

### 5. Entry Inhibitors

#### Fusion Inhibitors

- **Mechanism of Action**: Inhibit fusion of HIV with the host cell membrane.
- **Examples**: Enfuvirtide (T20).
- **Side Effects**: Injection site reactions, bacterial pneumonia.

#### CCR5 Antagonists

- **Mechanism of Action**: Block the CCR5 co-receptor on host cells, preventing HIV entry.
- **Examples**: Maraviroc (MVC).
- **Side Effects**: Hepatotoxicity, orthostatic hypotension, cough, upper respiratory infections.

## Combination Therapy

### Highly Active Anti-Retroviral Therapy (HAART)

- **Approach**: Combining drugs from different classes to enhance efficacy and reduce the likelihood of resistance.
- **Common Regimens**:
  - Two NRTIs + One NNRTI
  - Two NRTIs + One PI (boosted with ritonavir or cobicistat)
  - Two NRTIs + One INSTI

## Treatment Goals

- **Viral Suppression**: Reduce plasma HIV RNA to undetectable levels.
- **Immune Restoration**: Increase CD4+ T-cell count.
- **Prevent Opportunistic Infections**: Maintain immune function.
- **Reduce HIV Transmission**: Lowering viral load reduces the risk of transmission.

## Monitoring and Follow-Up

- **Viral Load Testing**: Regularly to ensure effective viral suppression.
- **CD4 Count**: To monitor immune status.
- **Resistance Testing**: If treatment failure is suspected.
- **Adherence**: Ensure patient adherence to therapy to prevent resistance.

## Side Effects and Management

- **Short-Term Side Effects**: GI upset, headache, fatigue, which often improve over time.
- **Long-Term Side Effects**: Metabolic complications, cardiovascular disease, renal and hepatic toxicity, requiring regular monitoring and management.
